Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-25 @ 8:20 PM
Study NCT ID:
NCT05919069
Status:
COMPLETED
Last Update Posted:
2024-11-25
First Post:
2023-06-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-16
First Submit QC Date:
None
Study First Post Date:
2023-06-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-22
Last Update Post Date:
2024-11-25
Last Update Post Date Type:
ACTUAL